Applied Genetic Technologies Corporation announced the appointments of William Sullivan to the position of Chief Financial Officer and Andrew Ashe to the position of General Counsel. Larry Bullock, who has served as Chief Financial Officer, is retiring. Mr. Sullivan has more than 20 years of experience in corporate finance, leading strategic transactions, fundraising, and accounting.

Prior to joining AGTC, he held a variety of important leadership positions at Merrimack Pharmaceuticals Inc., including Chief Financial Officer, Principal Accounting Officer and Treasurer. The company also announced the appointment of Andrew Ashe to General Counsel. Mr. Ashe brings over 25 years of experience to his role, most recently serving as Executive Vice President, Administration, Corporate Secretary and General Counsel, for Dyax Corp.

until it was acquired by Shire plc in 2016.